{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:08:27Z","timestamp":1779235707158,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004480","name":"Natural Science Foundation of Shanxi Province","doi-asserted-by":"crossref","award":["2023-JC-YB 701"],"award-info":[{"award-number":["2023-JC-YB 701"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82070054"],"award-info":[{"award-number":["82070054"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46809-y","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T07:35:40Z","timestamp":1775115340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PAK5 drives vascular remodeling in hypoxic pulmonary hypertension via Drp1-dependent mitochondrial midzone division"],"prefix":"10.1038","volume":"16","author":[{"given":"Junming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuwen","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenfei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukun","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhichao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"46809_CR1","doi-asserted-by":"crossref","unstructured":"Gali\u00e8, N., McLaughlin, V. V., Rubin, L. J. & Simonneau, G. An overview of the 6th world symposium on pulmonary hypertension. Eur. Respir. J. 53. (2019).","DOI":"10.1183\/13993003.02148-2018"},{"key":"46809_CR2","doi-asserted-by":"crossref","unstructured":"Simonneau, G. et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur. Respir J. 53. (2019).","DOI":"10.1183\/13993003.01913-2018"},{"key":"46809_CR3","doi-asserted-by":"crossref","unstructured":"Liu, Y. et al. Mitochondrial dysfunction and therapeutic perspectives in cardiovascular diseases. Int. J. Mol. Sci. ;23. (2022).","DOI":"10.3390\/ijms232416053"},{"key":"46809_CR4","doi-asserted-by":"publisher","first-page":"1079989","DOI":"10.3389\/fphys.2022.1079989","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang, W. et al. Mitochondrial dysfunction in pulmonary arterial hypertension. Front. Physiol. 13, 1079989 (2022).","journal-title":"Front. Physiol."},{"key":"46809_CR5","doi-asserted-by":"crossref","unstructured":"Colon Hidalgo, D. et al. Metabolism, mitochondrial dysfunction, and redox homeostasis in pulmonary hypertension. Antioxid. (Basel) 11. (2022).","DOI":"10.3390\/antiox11020428"},{"key":"46809_CR6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/j.2040-4603.2020.tb00125.x","volume":"10","author":"A Dasgupta","year":"2020","unstructured":"Dasgupta, A. et al. Mitochondria in the pulmonary vasculature in health and disease: Oxygen-sensing, metabolism, and dynamics. Compr. Physiol. 10, 713\u2013765 (2020).","journal-title":"Compr. Physiol."},{"key":"46809_CR7","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1161\/CIRCRESAHA.111.263848","volume":"110","author":"G Marsboom","year":"2012","unstructured":"Marsboom, G. et al. Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension. Circ. Res. 110, 1484\u20131497 (2012).","journal-title":"Circ. Res."},{"key":"46809_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1161\/CIRCULATIONAHA.117.031258","volume":"138","author":"KH Chen","year":"2018","unstructured":"Chen, K. H. et al. Epigenetic dysregulation of the dynamin-related Protein 1 binding partners MiD49 and MiD51 increases mitotic mitochondrial fission and promotes pulmonary arterial hypertension: Mechanistic and therapeutic implications. Circulation 138, 287\u2013304 (2018).","journal-title":"Circulation"},{"key":"46809_CR9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00109-017-1541-5","volume":"95","author":"C Ma","year":"2017","unstructured":"Ma, C. et al. MiR-125a regulates mitochondrial homeostasis through targeting mitofusin 1 to control hypoxic pulmonary vascular remodeling. J. Mol. Med. (Berl). 95, 977\u2013993 (2017).","journal-title":"J. Mol. Med. (Berl)"},{"key":"46809_CR10","doi-asserted-by":"publisher","first-page":"e13048","DOI":"10.1111\/cpr.13048","volume":"54","author":"W Feng","year":"2021","unstructured":"Feng, W. et al. ERK\/Drp1-dependent mitochondrial fission contributes to HMGB1-induced autophagy in pulmonary arterial hypertension. Cell. Prolif. 54, e13048 (2021).","journal-title":"Cell. Prolif."},{"key":"46809_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1089\/ars.2009.3013","volume":"13","author":"I Diebold","year":"2010","unstructured":"Diebold, I. et al. Reciprocal regulation of Rac1 and PAK-1 by HIF-1alpha: a positive-feedback loop promoting pulmonary vascular remodeling. Antioxid. Redox Signal. 13, 399\u2013412 (2010).","journal-title":"Antioxid. Redox Signal."},{"key":"46809_CR12","doi-asserted-by":"publisher","first-page":"112187","DOI":"10.1016\/j.yexcr.2020.112187","volume":"395","author":"Z Bao","year":"2020","unstructured":"Bao, Z. et al. PAK5 promotes the cell stemness ability by phosphorylating SOX2 in lung squamous cell carcinomas. Exp. Cell. Res. 395, 112187 (2020).","journal-title":"Exp. Cell. Res."},{"key":"46809_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41419-025-07657-2","volume":"16","author":"X Zhao","year":"2025","unstructured":"Zhao, X. et al. PAK5 promotes the trastuzumab resistance by increasing HER2 nuclear accumulation in HER2-positive breast cancer. Cell. Death Dis. 16, 323 (2025).","journal-title":"Cell. Death Dis."},{"key":"46809_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41392-020-00409-y","volume":"6","author":"DG Zhang","year":"2021","unstructured":"Zhang, D. G. et al. P21-activated kinase 5 potentiates the chemoresistant phenotype of liver cancer. Signal. Transduct. Target. Ther. 6, 47 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"46809_CR15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1139\/cjpp-2020-0539","volume":"99","author":"H Chen","year":"2021","unstructured":"Chen, H. et al. MiR-145-5p modulates lipid metabolism and M2 macrophage polarization by targeting PAK7 and regulating \u03b2-catenin signaling in hyperlipidemia. Can. J. Physiol. Pharmacol. 99, 857\u2013863 (2021).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"46809_CR16","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.7150\/ijbs.58102","volume":"17","author":"Y Xing","year":"2021","unstructured":"Xing, Y. et al. PAK5-mediated AIF phosphorylation inhibits its nuclear translocation and promotes breast cancer tumorigenesis. Int. J. Biol. Sci. 17, 1315\u20131327 (2021).","journal-title":"Int. J. Biol. Sci."},{"key":"46809_CR17","doi-asserted-by":"publisher","first-page":"6636","DOI":"10.1016\/j.bmcl.2013.10.051","volume":"23","author":"YY Wen","year":"2013","unstructured":"Wen, Y. Y., Wang, X. X., Pei, D. S. & Zheng, J. N. p21-Activated kinase 5: a pleiotropic kinase. Bioorg. Med. Chem. Lett. 23, 6636\u20136639 (2013).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"46809_CR18","doi-asserted-by":"publisher","first-page":"204062232211350","DOI":"10.1177\/20406223221135011","volume":"13","author":"J Wan","year":"2022","unstructured":"Wan, J. et al. Association between high-mobility group box 2 and subclinical hypertension-mediated organ damage in young adults. Ther. Adv. Chronic Dis. 13, 20406223221135011 (2022).","journal-title":"Ther. Adv. Chronic Dis."},{"key":"46809_CR19","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41419-022-05091-2","volume":"13","author":"R Liu","year":"2022","unstructured":"Liu, R. et al. FUNDC1-mediated mitophagy and HIF1\u03b1 activation drives pulmonary hypertension during hypoxia. Cell. Death Dis. 13, 634 (2022).","journal-title":"Cell. Death Dis."},{"key":"46809_CR20","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.jpha.2023.06.005","volume":"13","author":"XL Liang","year":"2023","unstructured":"Liang, X. L. et al. Histone deacetylase inhibitor pracinostat suppresses colorectal cancer by inducing CDK5-Drp1 signaling-mediated peripheral mitofission. J. Pharm. Anal. 13, 1168\u20131182 (2023).","journal-title":"J. Pharm. Anal."},{"key":"46809_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s12967-023-04270-9","volume":"21","author":"ZD Su","year":"2023","unstructured":"Su, Z. D., Li, C. Q., Wang, H. W., Zheng, M. M. & Chen, Q. W. Inhibition of DRP1-dependent mitochondrial fission by Mdivi-1 alleviates atherosclerosis through the modulation of M1 polarization. J. Transl Med. 21, 427 (2023).","journal-title":"J. Transl Med."},{"key":"46809_CR22","doi-asserted-by":"publisher","first-page":"110560","DOI":"10.1016\/j.biopha.2020.110560","volume":"130","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Duo, D., Yan, Y., He, R. & Wu, X. Magnesium lithospermate B ameliorates hypobaric hypoxia-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition and its potential targets. Biomed. Pharmacother. 130, 110560 (2020).","journal-title":"Biomed. Pharmacother"},{"key":"46809_CR23","doi-asserted-by":"publisher","first-page":"110803","DOI":"10.1016\/j.cellsig.2023.110803","volume":"110","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. PAK5 potentiates slug transactivation of N-cadherin to facilitate metastasis of renal cell carcinoma. Cell. Signal. 110, 110803 (2023).","journal-title":"Cell. Signal."},{"key":"46809_CR24","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41418-018-0178-4","volume":"26","author":"FC Huo","year":"2019","unstructured":"Huo, F. C., Pan, Y. J., Li, T. T., Mou, J. & Pei, D. S. PAK5 promotes the migration and invasion of cervical cancer cells by phosphorylating SATB1. Cell. Death Differ. 26, 994\u20131006 (2019).","journal-title":"Cell. Death Differ."},{"key":"46809_CR25","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/jama.2022.4402","volume":"327","author":"NF Ruopp","year":"2022","unstructured":"Ruopp, N. F. & Cockrill, B. A. Diagnosis and treatment of pulmonary arterial hypertension: A review. Jama 327, 1379\u20131391 (2022).","journal-title":"Jama"},{"key":"46809_CR26","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12931-021-01908-4","volume":"22","author":"X Cao","year":"2021","unstructured":"Cao, X. et al. TRB3 mediates vascular remodeling by activating the MAPK signaling pathway in hypoxic pulmonary hypertension. Respir Res. 22, 312 (2021).","journal-title":"Respir Res."},{"key":"46809_CR27","doi-asserted-by":"crossref","unstructured":"Riou, M., Enache, I., Sauer, F., Charles, A. L. & Geny, B. Targeting mitochondrial metabolic dysfunction in pulmonary hypertension: Toward new therapeutic approaches? Int. J. Mol. Sci. ;24. (2023).","DOI":"10.3390\/ijms24119572"},{"key":"46809_CR28","doi-asserted-by":"publisher","first-page":"106863","DOI":"10.1016\/j.phrs.2023.106863","volume":"195","author":"FC Huo","year":"2023","unstructured":"Huo, F. C. et al. HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5. Pharmacol. Res. 195, 106863 (2023).","journal-title":"Pharmacol. Res."},{"key":"46809_CR29","doi-asserted-by":"publisher","first-page":"117113","DOI":"10.1016\/j.lfs.2019.117113","volume":"241","author":"YK Li","year":"2020","unstructured":"Li, Y. K. et al. Human p21-activated kinase 5 (PAK5) expression and potential mechanisms in relevant cancers: Basic and clinical perspectives for molecular cancer therapeutics. Life Sci. 241, 117113 (2020).","journal-title":"Life Sci."},{"key":"46809_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.biocel.2014.08.012","volume":"55","author":"V Freund-Michel","year":"2014","unstructured":"Freund-Michel, V., Khoyrattee, N., Savineau, J. P., Muller, B. & Guibert, C. Mitochondria: roles in pulmonary hypertension. Int. J. Biochem. Cell. Biol. 55, 93\u201397 (2014).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"46809_CR31","doi-asserted-by":"publisher","first-page":"5526","DOI":"10.1128\/MCB.23.16.5526-5539.2003","volume":"23","author":"S Cotteret","year":"2003","unstructured":"Cotteret, S., Jaffer, Z. M., Beeser, A. & Chernoff, J. p21-Activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylating BAD. Mol. Cell. Biol. 23, 5526\u20135539 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"46809_CR32","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1161\/ATVBAHA.119.312946","volume":"39","author":"Y Zhao","year":"2019","unstructured":"Zhao, Y. et al. ALDH2 (aldehyde dehydrogenase 2) protects against hypoxia-induced pulmonary hypertension. Arterioscler. Thromb. Vasc Biol. 39, 2303\u20132319 (2019).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"46809_CR33","doi-asserted-by":"publisher","first-page":"913904","DOI":"10.3389\/fcell.2022.913904","volume":"10","author":"F Xiao","year":"2022","unstructured":"Xiao, F., Zhang, R. & Wang, L. Inhibitors of mitochondrial dynamics mediated by dynamin-related protein 1 in pulmonary arterial hypertension. Front. Cell. Dev. Biol. 10, 913904 (2022).","journal-title":"Front. Cell. Dev. Biol."},{"key":"46809_CR34","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41586-021-03510-6","volume":"593","author":"T Kleele","year":"2021","unstructured":"Kleele, T. et al. Distinct fission signatures predict mitochondrial degradation or biogenesis. Nature 593, 435\u2013439 (2021).","journal-title":"Nature"},{"key":"46809_CR35","doi-asserted-by":"crossref","unstructured":"Colpman, P. et al. The role of mitochondrial fission factor (MFF) and increased midzone mitochondrial fission in pulmonary arterial hypertension: Implications for proliferation, mitophagy, and apoptosis. Circulation 148. (2023).","DOI":"10.1161\/circ.148.suppl_1.15168"},{"key":"46809_CR36","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3389\/fphys.2018.00828","volume":"9","author":"L Tian","year":"2018","unstructured":"Tian, L. et al. Increased Drp1-mediated mitochondrial fission promotes proliferation and collagen production by right ventricular fibroblasts in experimental pulmonary arterial hypertension. Front. Physiol. 9, 828 (2018).","journal-title":"Front. Physiol."},{"key":"46809_CR37","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1161\/CIRCRESAHA.122.321200","volume":"133","author":"X Zhou","year":"2023","unstructured":"Zhou, X. et al. Endothelial FIS1 DeSUMOylation protects against hypoxic pulmonary hypertension. Circ. Res. 133, 508\u2013531 (2023).","journal-title":"Circ. Res."},{"key":"46809_CR38","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1038\/s41467-019-11500-6","volume":"10","author":"Y Luo","year":"2019","unstructured":"Luo, Y. et al. CD146-HIF-1\u03b1 hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension. Nat. Commun. 10, 3551 (2019).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46809-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46809-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46809-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:27:20Z","timestamp":1779233240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46809-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46809"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46809-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods are reported in accordance with ARRIVE guidelines (\n                      \n                      ). Protocols involving human were approved by The Medical Ethics Committee of Shanghai Pulmonary Hospital (Shanghai, China; approval no. L20-211). All animal procedures were approved by the Biomedical Ethics Committee of the Medical Department of Northwestern University and were conducted in accordance with the ethical guidelines for the use of experimental animals (approved number: IACUC-20250523R).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}],"article-number":"15674"}}